Finance

Beta
Lists
ACHV:NASDAQ
Achieve Life Sciences Inc
$5.30
0.00%
(0.00) 1D
Jun 24, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ACHV...
Mkt. cap
544.09M
Avg. vol.
1.73M
Volume
1.39K
52-wk high
$6.16
52-wk low
$2.00
EPS
-$1.11
Beta
2.27
Shares outstanding
102.66M
No. of employees
28
Mkt. cap
544.09M
Avg. vol.
1.73M
Volume
1.39K
52-wk high
$6.16
52-wk low
$2.00
EPS
-$1.11
Beta
2.27
Shares outstanding
102.66M
No. of employees
28
News stories
From sources across the web
About Achieve Life Sciences Inc
CEO-
Employees28
Founded1991
HeadquartersSeattle, Washington, United States
SectorBiotechnology
Websiteachievelifesciences.com
Analyst Ratings
Based on 5 analysts giving stock ratings to ACHV in the past 3 months
Strong Buy
Buy
5
Hold
0
Sell
0
12 month forecast
Based on 5 Wall Street analysts offering 12 month price targets for ACHV in the last 3 months.
Highest
Current $5.30
$20.00 (+277.36%)
Average
$13.20 (+149.06%)
Lowest
$10.00 (+88.68%)
Analyst
Recommendation
Action
Price Target
Projected
Date
Jason McCarthy
Maxim Group
Buy
Maintained
$10.00
+88.7%
06/22/2026
Gary Nachman
Canaccord Genuity
Buy
Reiterated
$13.00
+145.3%
06/23/2026
Brandon Folkes
H.C. Wainwright
Buy
Reiterated
$12.00
+126.4%
06/23/2026
Mark Smith
Lake Street
Buy
Maintained
$11.00
+107.5%
05/13/2026
Justin Walsh
JonesTrading
Buy
Reiterated
$20.00
+277.4%
05/12/2026
Unknown Analyst
Canaccord Genuity
Buy
Initiated
$13.00
+145.3%
04/20/2026
Thomas Flaten
Lake Street
Buy
Maintained
$11.00
+107.5%
04/15/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
6.71M
5.32M
3.87M
3.29M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
5.86M
9.37M
10.86M
7.17M
Operating expense
12.56M
14.69M
14.73M
10.46M
Total operating expenses
12.56M
14.69M
14.73M
10.46M
Operating income
-12.56M
-14.69M
-14.73M
-10.46M
Other non operating income
-59.00K
-5.00K
7.00K
-13.00K
EBT including unusual items
-12.72M
-14.44M
-14.66M
-10.17M
EBT excluding unusual items
-12.62M
-14.34M
-14.55M
-10.45M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-12.72M
-14.44M
-14.66M
-10.17M
Net profit margin
-
-
-
-
Earnings per share
-0.37
-0.28
-0.28
-0.19
Interest and investment income
192.00K
554.00K
427.00K
297.00K
Interest expense
-191.00K
-192.00K
-251.00K
-274.00K
Net interest expenses
1.00K
362.00K
176.00K
23.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-12.51M
-14.64M
-14.67M
-10.41M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer